Key Takeaways: Even with its latest product, MicroPort MedBot faces intensifying competition in the field of medical automation from dominant imports and rival Chinese devices
Key Takeaways: Income from new and innovative drugs boosted the company’s core pharmaceutical business, where revenues rose nearly 12% to 15.92 billion yuan But Fosun Pharma carries a heavy debt burden with 27.53 billion yuan of external guarantees By Molly Wen
Key Takeaways: New Horizon Health posted a 61.3 million yuan adjusted profit in the first half of 2023, benefiting from soaring revenue for its three approved products The company sees big growth potential for its home-based cervical cancer screening product By Molly Wen
Key Takeaways: Hygeia paid 1.66 billion yuan for all the shares in Chang’an Hospital, which has a track record of profitability Since the start of the Covid pandemic, the company has raised the quality of its acquisition targets and boosted the value of its goodwill By Molly Wen
Cash-strapped Viva Biotech Sells Stake And Plans Spinoff benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.